MEKRIV Trademark

Trademark Overview

On Monday, June 2, 2008, a trademark application was filed for MEKRIV with the United States Patent and Trademark Office. The USPTO has given the MEKRIV trademark a serial number of 77488545. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 27, 2018. This trademark is owned by AstraZeneca AB. The MEKRIV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory, central nervous and peripheral nervous systems; Pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer and diabetes
mekriv

General Information

Serial Number77488545
Word MarkMEKRIV
Filing DateMonday, June 2, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 27, 2018
Registration Number4027384
Registration DateTuesday, September 20, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory, central nervous and peripheral nervous systems; Pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer and diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 27, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje
SE

Trademark Events

Event DateEvent Description
Friday, April 27, 2018CANCELLED SEC. 8 (6-YR)
Tuesday, September 20, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, July 5, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2011PUBLISHED FOR OPPOSITION
Friday, May 27, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 23, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 23, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 23, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 23, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 9, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 9, 2010NON-FINAL ACTION E-MAILED
Thursday, December 9, 2010NON-FINAL ACTION WRITTEN
Friday, November 19, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 19, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 19, 2010ASSIGNED TO LIE
Thursday, November 4, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 4, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 4, 2010NON-FINAL ACTION E-MAILED
Tuesday, May 4, 2010NON-FINAL ACTION WRITTEN
Wednesday, April 14, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 14, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 14, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, October 15, 2009NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, October 15, 2009INQUIRY TO SUSPENSION E-MAILED
Thursday, October 15, 2009SUSPENSION INQUIRY WRITTEN
Friday, September 25, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, March 24, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, March 24, 2009LETTER OF SUSPENSION E-MAILED
Tuesday, March 24, 2009SUSPENSION LETTER WRITTEN
Wednesday, March 4, 2009EXAMINER'S AMENDMENT ENTERED
Tuesday, March 3, 2009ASSIGNED TO LIE
Tuesday, March 3, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 3, 2009EXAMINERS AMENDMENT E-MAILED
Tuesday, March 3, 2009EXAMINERS AMENDMENT -WRITTEN
Friday, September 12, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 12, 2008NON-FINAL ACTION E-MAILED
Friday, September 12, 2008NON-FINAL ACTION WRITTEN
Thursday, September 11, 2008ASSIGNED TO EXAMINER
Thursday, June 5, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

mekriv pharmaceutical treatment preparations nervous pain inflammation cancer diabetes systems infection